Sweden: Diaverum to list on Nasdaq Stockholm

Long expected, Swedish dialysis firm Diaverum has announced plans to raise €290m (US$344.3m) in an initial public offering on Nasdaq Stockholm. “Today’s announcement is a milestone for Diaverum and a proud moment for all our employees,” said chief executive Dimitris Moulavasilis. “We believe becoming a listed company will put us in a stronger position to…

You must be a HMI Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »